secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0000950170-21-002832
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q3 revenue $26.3M, up 91% YoY; raises 2021 guidance to $99-101M
------------------------------------------------------------------------------

- Revenue $26.3M (+91.3% YoY); product revenue $21.8M (+101.9% YoY).
- Net loss $30.5M ($0.65 loss per share); non-GAAP net loss $27.6M ($0.59).
- Gross margin improved to 11.2% from (37.3%) a year ago; product gross margin turned positive at 5.9%.
- FY2021 revenue guidance raised to $99-101M from prior $97-100M.
- Received favorable TPNIES decision for Tablo; cash balance $406.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/0000950170-21-002832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/om-20211103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-002832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer